Icotinib Hydrochloride

CAS: 1204313-51-8

Ref. TM-T2307

Produktinformation

• Name: Icotinib Hydrochloride
• Synonyme: BPI-2009H
• CAS: 1204313-51-8

Beschreibung

Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 427.88
• Formel: C₂₂H₂₂ClN₃O₄
• Reinheit: 99.77%
• Farbe/Form: Solid